4uye
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-2-oxo-6-(piperidin-1- yl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2-methoxybenzamide== | ==BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-2-oxo-6-(piperidin-1- yl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2-methoxybenzamide== | ||
| - | <StructureSection load='4uye' size='340' side='right' caption='[[4uye]], [[Resolution|resolution]] 1.65Å' scene=''> | + | <StructureSection load='4uye' size='340' side='right'caption='[[4uye]], [[Resolution|resolution]] 1.65Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4uye]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4UYE OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4UYE FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[4uye]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4UYE OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4UYE FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=9F9:N-[1,3-DIMETHYL-2-OXO-6-(PIPERIDIN-1-YL)-2,3-DIHYDRO-1H-BENZIMIDAZOL-5-YL]-2-METHOXYBENZAMIDE'>9F9</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=9F9:N-[1,3-DIMETHYL-2-OXO-6-(PIPERIDIN-1-YL)-2,3-DIHYDRO-1H-BENZIMIDAZOL-5-YL]-2-METHOXYBENZAMIDE'>9F9</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4uyd|4uyd]], [[4uyf|4uyf]], [[4uyg|4uyg]], [[4uyh|4uyh]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4uyd|4uyd]], [[4uyf|4uyf]], [[4uyg|4uyg]], [[4uyh|4uyh]]</td></tr> | ||
| Line 19: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 4uye" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 4uye" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Peregrin|Peregrin]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Human]] | ||
| + | [[Category: Large Structures]] | ||
[[Category: Bamborough, P]] | [[Category: Bamborough, P]] | ||
[[Category: Chung, C]] | [[Category: Chung, C]] | ||
Revision as of 09:04, 23 May 2019
BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-2-oxo-6-(piperidin-1- yl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2-methoxybenzamide
| |||||||||||
